Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a86c6129c62843b7bcd94ca6a10f2c16 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Guangting Zeng |e author |
| 700 | 1 | 0 | |a Yuchi Zhou |e author |
| 245 | 0 | 0 | |a Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection |
| 260 | |b Elsevier, |c 2023-10-01T00:00:00Z. | ||
| 500 | |a 2667-193X | ||
| 500 | |a 10.1016/j.lana.2023.100590 | ||
| 546 | |a EN | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n The Lancet Regional Health. Americas, Vol 26, Iss , Pp 100590- (2023) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2667193X23001643 | |
| 787 | 0 | |n https://doaj.org/toc/2667-193X | |
| 856 | 4 | 1 | |u https://doaj.org/article/a86c6129c62843b7bcd94ca6a10f2c16 |z Connect to this object online. |